Showing results (191-200 of 428) with videos related to
Sort By:
Pageof 43
Journal of Chromatography|February 12, 1993
Determination of oxiracetam in human plasma by reversed-phase high-performance liquid chromatography with fluorimetric detectionR C Simpson, V K Boppana, B Y Hwang, et al.Journal of Visualized Experiments : Jove|October 30, 2018
Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell ActivationElana Ben-Akiva, Kelly R Rhodes, Randall A Meyer, et al.TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|November 27, 2013
The effects of nuclear mutation on chloroplast development : Part 1: chloroplast DNA, proteins, ribosomes, hormones and tissue culturesS D Kung, P R Rhodes, T C Tso, et al.Journal of Virological Methods|November 13, 2015
The evaluation of hollow-fiber ultrafiltration and celite concentration of enteroviruses, adenoviruses and bacteriophage from different water matricesEric R Rhodes, Emma M Huff, Douglas W Hamilton, et al.Frontiers in Immunology|March 13, 2023
Common framework mutations impact antibody interfacial dynamics and flexibilityEmily R Rhodes, Jonathan G Faris, Brian M Petersen, et al.Current Molecular Medicine|February 22, 2007
Bioinformatics approaches in the study of cancerDavid A Hanauer, Daniel R Rhodes, Chandan Sinha-Kumar, et al.American Journal of Surgery|August 1, 1987
Popliteal-to-tibial in situ saphenous vein bypass for limb salvage in diabetic patientsG R Rhodes, D Rollins, A N Sidawy, et al.Journal of Chromatography|February 12, 1993
Column-switching high-performance liquid chromatographic method for the determination of SK&F 106203 in human plasma after fluorescence derivatization with 9-anthryldiazomethaneC Miller-Stein, B Y Hwang, G R Rhodes, et al.Antiviral Therapy|October 9, 2008
Effect of nucleoside and nucleotide reverse transcriptase inhibitors of HIV on endogenous nucleotide poolsJennifer E Vela, Michael D Miller, Gerald R Rhodes, et al.Clinical Pharmacology and Therapeutics|February 17, 2001
Clinical trial simulation of docetaxel in patients with cancer as a tool for dosage optimizationC Veyrat-Follet, R Bruno, R Olivares, et al.Pageof 43